Epidemiological profiling of SARS-CoV-2 with focus on one-health approaches in mitigating COVID-19 pandemic

SHIKA TAMTA; O R VINODHKUMAR; A KARTHIKEYAN; Z B DUBAL; SHARUN KHAN; ABDUL RAHMAN A SAIED; MANISH DHAWAN; KULDEEP DHAMA; Y S MALIK

doi:10.56093/ijans.v91i10.117206

Authors

SHIKA TAMTA ICAR-Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh 243 122 India
O R VINODHKUMAR ICAR-Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh 243 122 India
A KARTHIKEYAN ICAR-Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh 243 122 India
Z B DUBAL ICAR-Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh 243 122 India
SHARUN KHAN ICAR-Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh 243 122 India
ABDUL RAHMAN A SAIED National Food Safety Authority (NFSA), Aswan 81511, Egypt
MANISH DHAWAN Punjab Agricultural University, Ludhiana, Punjab
KULDEEP DHAMA ICAR-Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh 243 122 India
Y S MALIK Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana, Punjab

https://doi.org/10.56093/ijans.v91i10.117206

Keywords:

COVID-19, Emerging, Epidemiology, One health approach, Pandemic, Transmission, Vaccine

Abstract

Of the 1,415 human pathogens identified, 175 are responsible for causing emerging diseases, 132 are zoonotic and majority of the diseases are categorized as emerging or re-emerging. Emerging novel Coronavirus (COVID- 19) is one of them, and it is responsible for causing social and economically critical disease in both humans and animals. This review presents the understanding of epidemiological characteristics of the COVID-19 pandemic related to host, agent, and the environment with transmission and spread of the disease for better prevention of the COVID-19. The inclination of the viruses to spillover between different species and determining the number of the reservoir of coronaviruses in an entirely new host to create infection is of emerging importance. The understanding of disease patterns will potentiate our expertise to alert how, when, and where the potential epidemic will occur. One health approach involves co-operation from all the sectors, including healthcare (medical and veterinary), environmental, pharmaceutical, educational, research, police, and administration, to combat the COVID-19 pandemic and reduce the public health threat.

Downloads

Download data is not yet available.

References

1. Abdelgadir A, Vlasova A N and Gray G C. 2021. Susceptibility of different cell lines to the novel canine coronavirus CCoVHuPn-2018. Influenza and Other Respiratory Viruses 1–2. DOI: https://doi.org/10.1111/irv.12882

2. Aggarwal D and Ramachandran A. 2020. One health approach to address zoonotic diseases. Indian Journal of Community Medicine: Official Publication of Indian Association of Preventive and Social Medicine 45(Suppl 1): S6–S8. DOI: https://doi.org/10.4103/ijcm.IJCM_398_19

3. Aguiló-Gisbert J, Padilla-Blanco M, Lizana V, Maiques E, Muñoz-Baquero M, Chillida-Martínez E, Cardells J and Rubio-Guerri C. 2021. First Description of SARS-CoV-2 Infection in Two Feral American Mink (Neovison vison) Caught in the Wild. Animals 11(5): 1422. DOI: https://doi.org/10.3390/ani11051422

4. Anthony S J, Ojeda-Flores R, Rico-Chavez O, Navarrete-Macias I, Zambrana-Torrelio C M, Rostal M K, Epstein J H, Tipps T, Liang E, Sanchez-Leon M and Sotomayor-Bonilla J. 2013. Coronaviruses in bats from Mexico. Journal of General DOI: https://doi.org/10.1099/vir.0.049759-0

5. Virology 94: 1028.

6. Ashton J. 2021. The COVID-19 pandemic: The third wave?. Journal of the Royal Society of Medicine 114(7): 367–68. DOI: https://doi.org/10.1177/01410768211030835

7. Banerjee A, Mossman K and Baker M L. 2021. Zooanthroponotic potential of SARS-CoV-2 and implications of reintroduction into human populations. Cell Host and Microbe 29(2): 160–64. DOI: https://doi.org/10.1016/j.chom.2021.01.004

8. Bastola A, Sah R, Rodriguez-Morales A J, Lal B K, Jha R, Ojha H C, Shrestha B, Chu D K, Poon L L, Costello A and Morita K. 2020. The first 2019 novel coronavirus case in Nepal. Lancet Infectious Diseases 20: 279–80. DOI: https://doi.org/10.1016/S1473-3099(20)30067-0

9. Benkeblia N. 2021. In the landscape of SARS-CoV-2 and fresh fruits and vegetables: The fake and hidden transmission risks. Journal of Food Safety: e12898. DOI: https://doi.org/10.1111/jfs.12898

10. Bonilla-Aldana D K, Dhama K and Rodriguez-Morales A J. 2020. Revisiting the One Health Approach in the context of COVID-19: A look into the ecology of this emerging disease. Advances in Animal and Veterinary Sciences 8(3): 234–37. DOI: https://doi.org/10.17582/journal.aavs/2020/8.3.234.237

11. Centers for Disease Control and Prevention (2020). 2019. Novel Coronavirus. https://www.cdc.gov/Coronavirus/2019-ncov/about/transmission.html.

12. Chan J F, Li K S, To K K, Cheng V C, Chen H and Yuen K Y.2012. Is the discovery of the novel human betacoronavirus 2c

13. EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic. Journal of Infection 65: 477–89. DOI: https://doi.org/10.1016/j.jinf.2012.10.002

14. Chan K H, Poon L L, Cheng V C C, Guan Y, Hung I F N, Kong J, Yam L Y, Seto W H, Yuen K Y and Peiris J S M. 2004.

15. Detection of SARS coronavirus in patients with suspected SARS. Emerging Infectious Diseases 10(2): 294. DOI: https://doi.org/10.3201/eid1002.030610

16. Chen Z, Yu M, Wang Y and Zhou L. 2021. The effect of the synchronized multi-dimensional policies on imported COVID-19 curtailment in China. PLoS ONE 16(6): e0252224. DOI: https://doi.org/10.1371/journal.pone.0252224

17. Clinical Trials. gov. Identifier: NCT04379336. BCG Vaccination for Healthcare Workers in COVID-19 Pandemic 2020;

18. Available from: https://clinicaltrials.gov/ct2/show/NCT04379336].

19. Cui J, Li F and Shi Z L. 2019. Origin and evolution of pathogenic Coronaviruses. Nature Reviews Microbiology 17: 181–92. DOI: https://doi.org/10.1038/s41579-018-0118-9

20. Curtis N, Sparrow A, Ghebreyesus T A and Netea M G. 2020. Considering BCG vaccination to reduce the impact of COVID-19. Lancet, 395: 1545–46. DOI: https://doi.org/10.1016/S0140-6736(20)31025-4

21. Dasgupta R, Tomley F, Alders R, Barbuddhe S B and Kotwani A. 2021. Adopting an intersectoral One Health approach in India: Time for One Health committees. Indian Journal of Medical Research 153(3): 281–86. DOI: https://doi.org/10.4103/ijmr.IJMR_537_21

22. Davis M F and Innes G K. 2021. The Cat’s in the bag: Despite limited cat-to-cat severe acute respiratory syndrome coronavirus 2 transmission, One health surveillance efforts are needed. Journal of Infectious Diseases 223(8): 1309–12. DOI: https://doi.org/10.1093/infdis/jiab106

23. Delahay R J, de la Fuente J, Smith G C, Sharun K, Snary E L, Flores Girón L, Nziza J, Fooks A R, Brookes S M, Lean F Z

24. X, Breed A C and Gortazar C. 2021. Assessing the risks of SARS-CoV-2 in wildlife. One Health Outlook 3(1): 1–14. DOI: https://doi.org/10.1186/s42522-021-00039-6

25. Desai P, Gharpure K M, Bargaje C and Bakhle D. 2021. Med res. 1–6. How does covaxin compare with covishield? Which is better? https://www.bbc.com/news/world-asia-india-55748124.

26. Dhama K, Chakraborty S, Kapoor S, Tiwari R, Kumar A, Deb R, Rajagunalan S, Singh R, Vora K and Natesan S. 2013. One

27. world, one health–veterinary perspectives. Advances in Animal and Veterinary Sciences 1(1): 5–13.

28. Dhama K, Karthik K, Tiwari R, Khandia R, Munjal A, Chakraborty S, Yadav J P, Kumar D, Latheef S K, Saminathan

29. M, Malik Y S, Iqbal H M N. 2018. Zika virus / Zika fever: Acomprehensive update. Journal of Experimental Biology and

30. Agricultural Sciences 6(2): 1–31.

31. Dhama K, Patel S K, Sharun K, Pathak M, Tiwari R, Yatoo M I, Malik Y S, Sah R, Rabaan A A, Panwar P K, Singh K P,

32. Michalak I, Chaicumpa W, Martinez-Pulgarin D F, Bonilla-Aldana D K and Rodriguez-Morales A J. 2020a. SARS-CoV-

33. jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus. Travel Medicine and Infectious Disease 37:101830. DOI: https://doi.org/10.1016/j.tmaid.2020.101830

34. Dhama K, Patel S K, Yatoo M I, Tiwari R, Sharun K, Dhama J, Natesan S, Malik Y S, Singh K P and Harapan H. 2021. SARSCoV-2 existence in sewage and wastewater: A global public health concern? Journal of Environmental Management 280: 111825. DOI: https://doi.org/10.1016/j.jenvman.2020.111825

35. Dhama K, Sharun K, Tiwari R, Dadar M, Malik Y S, Singh K P and Chaicumpa W. 2020. COVID-19, an emerging coronavirus infection: Advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Human Vaccines and Immunotherapeutics 16: 1232–38. DOI: https://doi.org/10.1080/21645515.2020.1735227

36. Di Teodoro G, Valleriani F, Puglia I, Monaco F, Di Pancrazio C, Luciani M, Krasteva I, Petrini A, Marcacci M, D’Alterio N, Curini V and Lorusso A. 2021. SARS-CoV-2 replicates in respiratory ex vivo organ cultures of domestic ruminant DOI: https://doi.org/10.1016/j.vetmic.2020.108933

37. species. Veterinary Microbiology 252: 108933.

38. do Vale B, Lopes A P, Fontes M D C, Silvestre M, Cardoso L, Coelho A C. 2021. Bats, pangolins, minks and other animals-villains or victims of SARS-CoV-2?. Veterinary Research Communications 45(1): 1–19. DOI: https://doi.org/10.1007/s11259-021-09787-2

39. Eslami H and Jalili M. 2020. The role of environmental factors to transmission of SARS-CoV-2 (COVID-19). AMB Express 10: 1–8. DOI: https://doi.org/10.1186/s13568-020-01028-0

40. Fehr A R, Perlman S, Maier H J, Bickerton E and Britton P. 2015. Coronaviruses: an overview of their replication and DOI: https://doi.org/10.1007/978-1-4939-2438-7_1

41. pathogenesis. Methods in Molecular Biology 1282: 1–23.

42. Forstera B C, Forsterd L, Renfrewb C and Forsterc M. 2020. Phylogenetic network analysis of SARS-CoV-2. Genomes 117: 9241–43. DOI: https://doi.org/10.1073/pnas.2004999117

43. Ge X Y, Li J L, Yang X L, Chmura A A, Zhu G, Epstein J H, Mazet J K, Hu B, Zhang W, Peng C and Zhang Y J. 2013.

44. Isolation and characterization of a bat SARS-like Coronavirus that uses the ACE2 receptor. Nature 503: 535–38. DOI: https://doi.org/10.1038/nature12711

45. Ghareeb D A, Saleh S R, Nofal M S, Kaddah M M Y, Hassan S F, Seif I K, El-Zahaby S A, Khedr S M, Kenawy M Y, Masoud A A and Soudi S A. 2021. Potential therapeutic and pharmacological strategies for SARS-CoV2. Journal of DOI: https://doi.org/10.1007/s40005-021-00520-4

46. Pharmaceutical Investigation 51: 281–96.

47. Goldsmith C S, Tatti K M, Ksiazek T G, Rollin P E, Comer J A, Lee W W, Rota P A, Bankamp B, Bellini W J and Zaki S R.

48. Ultrastructural characterization of SARS coronavirus. Emerging Infectious Diseases 10: 320. DOI: https://doi.org/10.3201/eid1002.030913

49. Gortázar C, Barroso-Arévalo S, Ferreras-Colino E, Isla J, de la Fuente G, Rivera B, Domínguez L, de la Fuente J, Sánchez-Vizcaíno J M. 2021. Natural SARS-CoV-2 Infection in Kept Ferrets, Spain. Emerging Infectious Diseases 27(7): 1994–96. DOI: https://doi.org/10.3201/eid2707.210096

50. Graham R L, Donaldson E F and Baric R S. 2013. A decade after SARS: strategies for controlling emerging coronaviruses. Nature Reviews Microbiology 11: 836–48. DOI: https://doi.org/10.1038/nrmicro3143

51. Greenberg N, Docherty M, Gnanapragasam S, Wessely S. 2020. Managing mental health challenges faced by healthcare workers during covid-19 pandemic. BMJ 26: 368. DOI: https://doi.org/10.1136/bmj.m1211

52. Guan Y, Zheng B J, He Y Q, Liu X L, Zhuang Z X, Cheung C L, Luo S W, Li P H, Zhang L J, Guan Y J and Butt K M. 2003. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302: 276–78. DOI: https://doi.org/10.1126/science.1087139

53. Hamer S A, Ghai R R, Zecca I B, Auckland L D, Roundy C M, Davila E, Busselman R E, Tang W, Pauvolid-Corrêa A, Killian M L, Jenkins-Moore M, Torchetti M K, Robbe Austerman S, Lim A, Akpalu Y, Fischer R S B, Barton Behravesh C and Hamer G L. 2021. SARS-CoV-2 B.1.1.7 variant of concern detected in a pet dog and cat after exposure to a person with DOI: https://doi.org/10.21203/rs.3.rs-418665/v1

54. COVID-19, USA. Transboundary and Emerging Diseases 6:10.1111/tbed.14122.

55. Hawryluck L, Gold W L, Robinson S, Pogorski S, Galea S and Styra R. 2004. SARS control and psychological effects of

56. quarantine, Toronto, Canada. Emerging Infectious Diseases 10(7): 1206–12.

57. He B, Zhang Y, Xu L, Yang W, Yang F, Feng Y, Xia L, Zhou J, Zhen W, Feng Y and Guo H. 2014. Identification of diverse

58. alphacoronaviruses and genomic characterization of a novel severe acute respiratory syndrome-like coronavirus from bats in China. Journal of virology 88: 7070–82. DOI: https://doi.org/10.1128/JVI.00631-14

59. Hedman H D, Krawczyk E, Helmy Y A, Zhang L and Varga C. 2021. Host diversity and potential transmission pathways of SARS-CoV-2 at the human-animal interface. Pathogens 10(2): 180. DOI: https://doi.org/10.3390/pathogens10020180

60. Hui D S, Azhar E I, Madani T A, Ntoumi F, Kock R, Dar O, Ippolito G, Mchugh T D, Memish Z A, Drosten C and Zumla

61. A. 2020. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-The latest 2019 novel

62. coronavirus outbreak in Wuhan, China. International Journal of Infectious Diseases 91: 264–66.

63. Hurst K R, Koetzner C A and Masters P S. 2013. Characterization of a critical interaction between the coronavirus nucleocapsid protein and nonstructural protein 3 of the viral replicasetranscriptase complex. Journal of Virology 87: 9159–72. DOI: https://doi.org/10.1128/JVI.01275-13

64. Jemeršiæ L, Lojkiã I, Krešiã N, Keros T, Zelenika T A, Jurinoviã L, Skok D, Bata I, Boras J, Habrun B and Brniæ D. 2021.

65. Investigating the presence of SARS CoV-2 in free-living and captive animals. Pathogens 10(6): 635. DOI: https://doi.org/10.3390/pathogens10060635

66. Jorwal P, Bharadwaj S and Jorwal P. 2020. One health approach and COVID-19: A perspective. Journal of Family Medicine and Primary Care 9(12): 5888–91. DOI: https://doi.org/10.4103/jfmpc.jfmpc_1058_20

67. Joshi A and Paul S. 2020. Phylogenetic analysis of the novel coronavirus reveals important variants in Indian strains. DOI: https://doi.org/10.1101/2020.04.14.041301

68. BioRxiv.

69. Kang M, Wei J, Yuan J, Guo J, Zhang Y, Hang J, Qu Y, Qian H,Zhuang Y, Chen X and Peng X, 2020. Probable evidence of

70. fecal aerosol transmission of SARS-CoV-2 in a high-rise building. Annals of Internal Medicine 173(12): 974–80. DOI: https://doi.org/10.7326/M20-0928

71. Kim J M, Chung Y S, Jo H J, Lee N J, Kim M S, Woo S H, Park S, Kim J W, Kim H M and Han M G. 2020. Identification of coronavirus isolated from a patient in Korea with COVID-19. Osong Public Health and Research Perspectives 11: 3. DOI: https://doi.org/10.24171/j.phrp.2020.11.1.02

72. Korath A D J, Janda J, Untersmayr E, Sokolowska M, Feleszko W, Agache I, Adel Seida A, Hartmann K, Jensen-Jarolim E

73. and Pali-Schöll I. 2021. One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-Cov-2. Allergy 2021 Jun 28.

74. Lassaunière R, Fonager J, Rasmussen M, Frische A, Polacek C, Rasmussen T B, Lohse L, Belsham G J, Underwood A,

75. Winckelmann A A, Bollerup S, Bukh J, Weis N, Sækmose S G, Aagaard B, Alfaro-Núñez A, Mølbak K, Bøtner A and

76. Fomsgaard A. 2021. In vitro characterization of fitness and convalescent antibody neutralization of SARS-CoV-2 Cluster 5 variant emerging in mink at Danish farms. Frontiers in Microbiology 12: 698944. DOI: https://doi.org/10.3389/fmicb.2021.698944

77. Lee C T, Slavinski S, Schiff C, Merlino M, Daskalakis D, Liu D, Rakeman J L, Misener M, Thompson C, Leung Y L and Varma J K. 2017. Outbreak of influenza A (H7N2) among cats in an animal shelter with cat-to-human transmission—New York City. Clinical Infectious Diseases 65(11): 1927–29. DOI: https://doi.org/10.1093/cid/cix668

78. Li H, Mendelsohn E, Zong C, Zhang W, Hagan E, Wang N, Li S, Yan H, Huang H, Zhu G and Ross N. 2019. Human-animal interactions and bat coronavirus spillover potential among rural residents in Southern China. Biosafety and Health 1: 84–90. DOI: https://doi.org/10.1016/j.bsheal.2019.10.004

79. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung K S, Lau E H, Wong J Y and Xing X. 2020. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England Journal of Medicine 382: 1199–1207. DOI: https://doi.org/10.1056/NEJMoa2001316

80. Lin X, Gong Z, Xiao Z, Xiong J, Fan B and Liu J. 2020. Novel coronavirus pneumonia outbreak in 2019: Computed

81. tomographic findings in two cases. Korean Journal of Radiology 21: 365.

82. Lu H, Stratton C W and Tang Y. 2020. Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle. Journal of Medical Virology 92: 256–78. DOI: https://doi.org/10.1002/jmv.25678

83. Magalhaes E, Stoner A, Palmer J, Schranze R, Grandy S, Amin Sand Cheng N. 2021. An assessment of mental health outcomes during the COVID-19 pandemic. Community Mental Health Journal 20: 1–11. DOI: https://doi.org/10.1007/s10597-021-00876-9

84. Malik Y S, Kumar N, Sircar S, Kaushik R, Bhat S, Dhama K, Gupta P, Goyal K, Singh M P, Ghoshal U, El Zowalaty M E,

85. O R V, Yatoo M I, Tiwari R, Pathak M, Patel S K, Sah R, Rodriguez-Morales A J, Ganesh B, Kumar P and Singh R K.

86. b. Coronavirus Disease Pandemic (COVID-19): Challenges and a global perspective. Pathogens 9(7): 519. DOI: https://doi.org/10.3390/pathogens9070519

87. Malik Y S, Sircar S, Bhat S, Sharun K, Dhama K, Dadar M, Tiwari R and Chaicumpa W. 2020. Emerging novel coronavirus (2019-nCoV)—Current scenario, evolutionary perspective based on genome analysis and recent developments. Veterinary Quarterly 40: 68–76. DOI: https://doi.org/10.1080/01652176.2020.1727993

88. Martina B E, Haagmans B L, Kuiken T, Fouchier R A, Rimmelzwaan G F, Van Amerongen G, Peiris J M, Lim W and

89. Osterhaus A D. 2003. SARS virus infection of cats and ferrets. Nature 425: 915. DOI: https://doi.org/10.1038/425915a

90. Maurin M, Fenollar F, Mediannikov O, Davoust B, Devaux C and Raoult D. 2021. Current status of putative animal sources of SARS-CoV-2 infection in humans: Wildlife, domestic animals and pets. Microorganisms 9(4): 868. DOI: https://doi.org/10.3390/microorganisms9040868

91. Menachery V D, Yount B L, Kari D K, Agnihothram S, Gralinski, L E, Plante J A and Graham R L. 2015. A SARS-like cluster of circulating bat Coronaviruses shows potential for human emergence. Nature Medicine 21: 1508–13. DOI: https://doi.org/10.1038/nm.3985

92. Miller A, Reandelar M J, Fasciglione K, Roumenova V, Li Y and Otazu G H. 2020. Correlation between universal BCG

93. vaccination policy and reduced mortality for COVID-19. MedRxiv. Mobasheri A. 2020. COVID-19, Companion animals, comparative medicine, and one health. Frontiers in Veterinary Science 7: 522. DOI: https://doi.org/10.3389/fvets.2020.00522

94. Morens D M, Folkers G K and Fauci A S. 2004. The challenge of emerging and re-emerging infectious diseases. Nature 430: 242–49. DOI: https://doi.org/10.1038/nature02759

95. Müller M A, Meyer B, Corman V M Al-Masri M, Turkestani A, Ritz D, Sieberg A, Aldabbagh S, Bosch B J, Lattwein E and

96. Alhakeem R F. 2015. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: A nationwide, cross-sectional, serological study. Lancet Infectious Diseases 15(5): 559–64. DOI: https://doi.org/10.1016/S1473-3099(15)70090-3

97. Núñez-Delgado A. 2020. What do we know about the SARSCoV-2 coronavirus in the environment? Science of the Total Environment 727: 138647. DOI: https://doi.org/10.1016/j.scitotenv.2020.138647

98. Orive G, Lertxundi U and Barcelo D. 2020. Early SARS-CoV-2 outbreak detection by sewage-based epidemiology. Science of the Total Environment 732: 139298 DOI: https://doi.org/10.1016/j.scitotenv.2020.139298

99. Pérez-Abeledo M and Sanz J C. 2021. Variants de SARS-CoV-2, una historia todavía inacabada [SARS-CoV-2 variants, a still unfinished story]. Vacunas. Spanish. DOI: https://doi.org/10.1016/j.vacun.2021.06.003

100. Phan T. 2020. Novel coronavirus: From discovery to clinical diagnostics. Infection, Genetics and Evolution 79: 104211. DOI: https://doi.org/10.1016/j.meegid.2020.104211

101. Rabaan A A, Al-Ahmed S H, Sah R, Alqumber M A, Haque S, Patel S K, Pathak M, Tiwari R, Yatoo M I, Haq A U, Bilal M, Dhama K and Rodriguez-Morales A J. 2021. MERS-CoV: epidemiology, molecular dynamics, therapeutics, and future DOI: https://doi.org/10.1186/s12941-020-00414-7

102. challenges. Annals of Clinical Microbiology and Antimicrobials 20(1): 1–14.

103. Rabinowitz P M, Kock R, Kachani M, Kunkel R, Thomas J, Gilbert J, Wallace R, Blackmore C, Wong D, Karesh W,

104. Natterson B, Dugas R and Rubin C. 2013. Toward proof of concept of a one health approach to disease prediction andcontrol. Emerging Infectious Diseases 19(12): e130265. DOI: https://doi.org/10.3201/eid1912.130265

105. Ravichandran K, Anbazhagan S, Singh S V, Agri H, Rupner R N, Rajendran V K O, Dhama K and Singh B R. 2020. Global

106. status of COVID-19 diagnosis: An overview. Journal of Pure and Applied Microbiology 14: 879–92. DOI: https://doi.org/10.22207/JPAM.14.SPL1.25

107. Rodrigo C, Leonardi Bee J, Nguyen Van Tam J and Lim W S. 2016. Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database of Systematic Reviews 2(2): CD010406. DOI: https://doi.org/10.1002/14651858.CD010406.pub2

108. Rothe C and Sothmann S M. 2020. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. New England Journal of Medicine 382: 970–71. DOI: https://doi.org/10.1056/NEJMc2001468

109. Saied A A, Metwally A A, Mohamed H M and Haridy M A. 2021. The contribution of bovines to human health against viral infections. Environmental Science and Pollution Research 16: 1–25.

110. Sanchez-Galan J E, Ureña G, Escovar L F, Fabrega-Duque J R, Coles A, Kurt Z. 2021. Challenges to detect SARS-CoV-2 on environmental media, the need and strategies to implement the detection methodologies in wastewaters. Journal of Environmental Chemical Engineering 9(5): 105881. DOI: https://doi.org/10.1016/j.jece.2021.105881

111. Schulz L L and Tonsor G T. 2015. Assessment of the economic impacts of porcine epidemic diarrhea virus in the United States. Journal of Animal Science 93: 5111–18. DOI: https://doi.org/10.2527/jas.2015-9136

112. Sexton N R, Smith E C, Blanc H, Vignuzzi M, Peersen O B and Denison M R. 2016. Homology-based identification of a

113. mutation in the coronavirus RNA-dependent RNA polymerase that confers resistance to multiple mutagens. Journal of Virology 90: 7415–28. DOI: https://doi.org/10.1128/JVI.00080-16

114. Sharun K, Dhama K, Pawde A M, Gortázar C, Tiwari R, Bonilla-Aldana D K, Rodriguez-Morales A J, de la Fuente J, Michalak I and Attia Y A. 2021a. SARS-CoV-2 in animals: potential for unknown reservoir hosts and public health implications. Veterinary Quarterly 41(1): 181–201. DOI: https://doi.org/10.1080/01652176.2021.1921311

115. Sharun K, Tiwari R, Dhama K, Emran T B, Rabaan A A and Al Mutair A. 2021c. Emerging SARS-CoV-2 variants: Impact on vaccine efficacy and neutralizing antibodies. Human Vaccines and Immunotherapeutics 23: 1–4. DOI: https://doi.org/10.1080/21645515.2021.1923350

116. Sharun K, Tiwari R, Natesan S and Dhama K. 2021b. SARSCoV-2 infection in farmed minks, associated zoonotic concerns, and importance of the One Health approach during the ongoing COVID-19 pandemic. Veterinary Quarterly 41(1): 50–60. DOI: https://doi.org/10.1080/01652176.2020.1867776

117. Shi J, Wen Z, Zhong G, Yang H, Wang C, Huang B, Liu R, He X, Shuai L, Sun Z and Zhao Y. 2020. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2. Science 368: 1016–20. DOI: https://doi.org/10.1126/science.abb7015

118. Singh B R, Gandharva R, Karthikeyan R, Singh S V, Yadav A, Vinodh Kumar O R, Sinha D K, Jayakumar V, Dhama K,

119. Kumar D and Gandharava S. 2020. Epidemiological determinants of acute respiratory syndrome coronavirus-2 disease pandemic and the role of the Bacille-Calmette-Guerin vaccine in reducing morbidity and mortality. Journal of Pure and Applied Microbiology 14: 1007–16. DOI: https://doi.org/10.22207/JPAM.14.SPL1.39

120. Singh R K, Dhama K, Chakraborty S, Tiwari R, Natesan S, Khandia R, Munjal A, Vora K S, Latheef S K, Karthik K,

121. Singh Malik Y, Singh R, Chaicumpa W and Mourya D T. 2019. Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies—A comprehensive review. Veterinary Quarterly 39(1): 26–55. DOI: https://doi.org/10.1080/01652176.2019.1580827

122. Smith I and Wang L F. 2013. Bats and their virome: An important source of emerging viruses capable of infecting humans. Current Opinion in Virology 3: 84–91. DOI: https://doi.org/10.1016/j.coviro.2012.11.006

123. Soté W O, Franca E F, Hora A S and Comar M. 2021. A computational study of the interface interaction between SARS-CoV-2 RBD and ACE2 from human, cat, dog and ferret. Authorea Preprints 12. DOI: https://doi.org/10.22541/au.161539677.73493964/v1

124. Tang X C, Zhang J X, Zhang S Y, Wang P, Fan X H, Li L F, Li G, Dong B Q, Liu W, Cheung C L and Xu K M. 2006. Prevalence and genetic diversity of coronaviruses in bats from China. Journal of Virology 80: 7481–90. DOI: https://doi.org/10.1128/JVI.00697-06

125. Taylor L H, Latham S M and Woolhouse M E. 2001. Risk factors for human disease emergence. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 356: 983–89. DOI: https://doi.org/10.1098/rstb.2001.0888

126. Tiwari R, Dhama K, Sharun K, Iqbal Yatoo M, Malik Y S, Singh R, Michalak I, Sah R, Bonilla-Aldana D K and Rodriguez-

127. Morales A J. 2020. COVID-19: Animals, veterinary and zoonotic links. Veterinary Quarterly 40(1): 169–82. DOI: https://doi.org/10.1080/01652176.2020.1766725

128. To K K W, Tsang O T Y, Yip C C Y, Chan K H, Wu T C, Chan J M C, Leung W S, Chik T S H, Choi C Y C, Kandamby D H and Lung D C. 2020. Consistent detection of 2019 novel coronavirus in saliva. Clinical Infectious Diseases 71: 841–43. DOI: https://doi.org/10.1093/cid/ciaa149

129. van Aart A E, Velkers F C, Fischer E A J, Broens E M, Egberink H, Zhao S, Engelsma M, Hakze-van der Honing R W, Harders F, de Rooij M M T, Radstake C, Meijer P A, Oude Munnink B B, de Rond J, Sikkema R S, van der Spek A N, Spierenburg M, Wolters W J, Molenaar R J, Koopmans M P G, van der Poel W H M, Stegeman A and Smit L A M. 2021. SARS-CoV- 2 infection in cats and dogs in infected mink farms. Transboundary and Emerging Diseases 3: 10. DOI: https://doi.org/10.22541/au.161821264.49927405/v1

130. Vlasova A N, Diaz A, Damtie D, Xiu L, Toh T H, Lee J S, Saif L J and Gray G C. 2021. Novel canine coronavirus isolated from a hospitalized pneumonia patient, East Malaysia. Clinical Infectious Diseases 20: 456. DOI: https://doi.org/10.1093/cid/ciab456

131. Walls A C, Park Y J, Tortorici M A, Wall A, McGuire A T and Veesler D. 2020. Structure, function, and antigenicity of the

132. SARS-CoV-2 spike glycoprotein. Cell 181(2): 281–92.

133. Wang C, Pan R, Wan X, Tan Y, Xu L, Ho C S and Ho R C. 2020. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. International Journal of Environmental Research And Public Health 17(5): 1729. DOI: https://doi.org/10.3390/ijerph17051729

134. Wang L F, Shi Z, Zhang S, Field H, Daszak P and Eaton B T. 2006. Review of bats and SARS. Emerging Infectious DOI: https://doi.org/10.3201/eid1212.060401

135. Diseases 12: 1834.

136. Wang X W, Li J, Guo T, Zhen B, Kong Q, Yi B, Li Z, Song N, Jin M, Xiao W and Zhu X. 2005. Concentration and detection of SARS coronavirus in sewage from Xiao Tang Shan Hospital and the 309th Hospital of the Chinese People’s Liberation Army. Water Science and Technology 52(8): 213–21. DOI: https://doi.org/10.2166/wst.2005.0266

137. WHO. 2020. Coronavirus disease (COVID-2019) situation reports. https://www.who.int/docs/default-source/Coronaviruse/situation-reports/20200315-sitrep-55-covid-19.pdf?sfvrsn=33daa5cb_6 (accessed March 16, 2020).

138. WHO. 2021a. WHO COVID-19 Dashboard - Up to date data on pandemic. https://covid19.who.int/?gclid=CjwKCAiApNSABhAlEiwANuR9YM0k0JigJ56NivXbxLo_GNuUC2W0j79EBV9ZLho5WBFDR7AO8Bt2ihoCqfoQAvD_BwE Accessed on 4th August, 2021.

139. WHO. 2021b. DRAFT landscape of COVID-19 candidate vaccines https://www.who.int/publications/m/item/draftlandscape-of-covid-19-candidate-vaccines Accessed on 4th August, 2021.

140. WHO. Infection prevention and control during health care when COVID-19 is suspected https://www.who.int/publicationsdetail/infection-prevention-and-control-during-health-carewhen-novel-coronavirus-(ncov)-infection-is-suspected-20200125.

141. WHO. 2020. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-9). February, 2020. https://www.who.int/docs/default-source/Coronaviruse/who-chinajoint-mission-on-covid-19-final-report.pdf (accessed March 13, 2020).

142. WHO. 2020. Water, sanitation, hygiene and waste management for COVID19: Technical brief, 03 March 2020. World Health Organization, Geneva. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/infection-prevention-and-control.

143. Woo P C, Lau S K, Lam C S, Lau C C, Tsang A K, Lau J H, Bai R, Teng J L, Tsang C C, Wang M and Zheng B J. 2012.

144. Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus. Journal of Virology 86: 3995–4008. DOI: https://doi.org/10.1128/JVI.06540-11

145. Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, Wang Q, Xu Y, Li M, Li X and Zheng M. 2020. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B 10: 766–88. DOI: https://doi.org/10.1016/j.apsb.2020.02.008

146. Yinon M, Bar O, Flamholz A, Philips R and Milo R. 2020. SARSCOV-2 (COVID-19) by the numbers. eLife 9: e57309. DOI: https://doi.org/10.7554/eLife.57309

147. Zhang Y, Zhang C and Zheng W. 2020. More evidence suggests Pangolins may have passed coronavirus from Bats to Humans. Science Alert.

148. Zhao L, Jha B K, Wu A, Elliott R, Ziebuhr J, Gorbalenya A E, Silverman R H and Weiss S R. 2012. Antagonism of the

149. interferon-induced OAS-RNase L pathway by murine Coronavirus ns2 protein is required for virus replication and liver pathology. Cell Host and Microbe 11: 607–16. DOI: https://doi.org/10.1016/j.chom.2012.04.011

150. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X and Guan L. 2020. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 395: 1054–62. DOI: https://doi.org/10.1016/S0140-6736(20)30566-3

151. Zhou P, Yang X L, Wang X G, Hu B, Zhang L, Zhang W, Si H R, Zhu Y, Li B, Huang C L and Chen H D. 2020. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798): 270–73. DOI: https://doi.org/10.1038/s41586-020-2012-7

152. Zhu N, Zhang D and Wang W. 2020. A novel coronavirus from patients with pneumonia in China. New England Journal of Medicine 382: 727–33. DOI: https://doi.org/10.1056/NEJMoa2001017

153. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J and Guo Q. 2020. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. New England Journal of Medicine 382: 1177–79. DOI: https://doi.org/10.1056/NEJMc2001737